NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
en | boerse | 67931567 |
